MANAGEMENT STYLE
ASSETS UNDER MGMT
0 bp
EXPENSES
Fund Basics
Fund sponsor | |
Category | |
Asset class | |
Website | link... |
Inception date | Dec 03, 2024 |
Assets (mns) | $0 |
Expense ratio | 0 bp |
Currency |
Sector Breakdown
Fund Structure
Regulation | |
Distributions | |
Taxation | |
Stock selection | |
Weighting | |
Holdings Transparency | |
Derivatives-based | No |
Options available | No |
Currency hedged | No |
Fund of funds | No |
Top 10 Holdings
JUMIA TECHNOLOGIES AG SPONSORED ADR | 2.7 % |
VERVE THERAPEUTICS, INC. | 2.7 % |
OUSTER, INC. | 2.6 % |
IROBOT CORP | 2.6 % |
LUCID GROUP, INC. | 2.6 % |
AVIDITY BIOSCIENCES INC | 2.6 % |
ROCKET LAB USA, INC. | 2.4 % |
ALLOGENE THERAPEUTICS, INC. | 2.4 % |
LUMINAR TECHNOLOGIES, INC. CLASS A | 2.4 % |
RUMBLE, INC. CLASS A | 2.4 % |
Constituent Breakdown
Number of holdings | |
Herfindahl-Hirschman Index | 0 |
Wgt avg mkt cap (mns) | $0 |
Large cap (>$10bn) | 0.0% |
Mid cap ($2-10bn) | 0.0% |
Small cap (<$2bn) | 0.0% |
Developed mkts. | 0.0% |
Emerging mkts. | 0.0% |
Country Exposure
UNITED STATES | 79.4 % | |
ISRAEL | 5.2 % | |
BRITAIN | 4.2 % | |
CHINA | 3.9 % | |
GERMANY | 2.7 % | |
CANADA | 1.7 % |
Historical Performance
Standardized Performance (as of 12/03/2024)
YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | Incep. | |
---|---|---|---|---|---|---|---|
Total Returns | -- | -- | -- | -- | -- | -- | -- | Volatility | -- | -- | -- | -- | -- | -- | -- |
Market Correlations
versus... | Beta | R-squared |
S&P 500 | 0.00 | 0% |
MSCI EAFE | 0.00 | 0% |
MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
Avg. volume (000) | 0 |
Turnover | 0.0% |
Avg. Bid/Ask (% of price) | 0.00% |
ADV of underlying (mns) | $0 |
Technical Indicators
Recent close | $0.00 |
30d moving avg. | $0.00 |
Annualized volatility | 0.0% |
Relative strength (RSI) | 0 |
Short interest (ETF) | 0.0% |
Short interest (underlying) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
Ticker | Fund Name | Overlap vs. |
Expenses vs. |
ALTAR Score™ vs. |
---|
Risk and Returns: vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
E | E | |||||||
---|---|---|---|---|---|---|---|---|
Sales per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Book value per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
E | Fwd Est | E | ||
Price-to-sales | --x | --x | --x | --x |
Price-to-earnings | --x | --x | --x | --x |
Price-to-cash flow | --x | --x | --x | --x |
Price-to-growth | --x | --x | --x | --x |
Price-to-book value | --x | --x | --x | --x |
Yield | --% | --% | --x | --% |
Based on closing prices from 12/3/2024
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
ALTAR Score™
0.0%
Cat. Avg
0.0%
ALTAR Score™ Calculation
Category Overview
There are funds in the Equity category, with an average ALTAR Score™
of 0.0% and a standard deviation of
0.0%. 's ALTAR Score™ is approximately
0.0 standard deviations
below
the category average. This places in the percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
SELL
U/W
HOLD
O/W
BUY
Expense Analysis
Peer Group | ETFs |
# of ETFs | 609 |
Avg. Expense Ratio | 46.6 bp |
Std. Deviation | 32.9 bp |
(0 bp) Percentile rank | 0 |
Peer Group Expense Ratio Distribution
Total Cost of Ownership (TCO) Comparison
Expense (bp) (A) |
Avg. Bid/Ask (bp) (B) |
TCO (bp) (A)+(B) |
|
---|---|---|---|
0.0 | 0.0 | 0 | |
Peer Avg. | 37.1 | 14.9 | 52.1 |
For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .